Research map: Towards implementation of precision medicine biomarkers in early detection and prognostication of prostate cancer

Back to the article

Papers in this map

  1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries · Freddie Bray · 2024 · 26051 citations · Cited by this paper
  2. From bench to bedside: advancing our understanding of radioresistance in rectal cancer · 2026 · Related
  3. Integrative Clinical Genomics of Advanced Prostate Cancer · Dan R. Robinson · 2015 · 3730 citations · Cited by this paper
  4. Ferroptosis at the intersection of radiotherapy and immunotherapy · 2025 · Related
  5. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients · Ahmet Zehir · 2017 · 3590 citations · Cited by this paper
  6. The link between microplastics and colorectal cancer · 2026 · Related
  7. AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer · Emmanuel S. Antonarakis · 2014 · 2747 citations · Cited by this paper
  8. Tumor exosomes impact functional hallmarks of cancer · 2026 · Related
  9. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2 · Barış Türkbey · 2019 · 2532 citations · Cited by this paper
  10. Combining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group · 2025 · Related
  11. Advances in epigenetics link genetics to the environment and disease · Giacomo Cavalli · 2019 · 1573 citations · Cited by this paper
  12. Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development · 2026 · Related
  13. Genomic correlates of clinical outcome in advanced prostate cancer · Wassim M. Abida · 2019 · 1467 citations · Cited by this paper
  14. Single-cell and spatial RNA sequencing in prostate cancer · 2026 · Related
  15. Epigenetic plasticity and the hallmarks of cancer · William A. Flavahan · 2017 · 1403 citations · Cited by this paper
  16. Androgen Receptor Signalling in Prostate Cancer: Mechanisms of Resistance to Endocrine Therapies · 2025 · Related
  17. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance · Sheng‐Yu Ku · 2017 · 1144 citations · Cited by this paper
  18. Written in blood: DNA methylation in liquid biopsy · 2026 · Related
  19. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer · Ping Mu · 2017 · 1092 citations · Cited by this paper
  20. Plasma circulating tumor DNA methylation enables non-invasive disease stratification beyond PSA in prostate cancer · 2025 · Related
  21. Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers · Richard M Simon · 2009 · 1047 citations · Cited by this paper
  22. Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer · Qianben Wang · 2009 · 913 citations · Cited by this paper
  23. Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study · Jack M. Cuzick · 2011 · 822 citations · Cited by this paper
  24. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy · James McKiernan · 2016 · 684 citations · Cited by this paper
  25. A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling · Eric A. Klein · 2014 · 681 citations · Cited by this paper
  26. Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy · Nicholas Erho · 2013 · 673 citations · Cited by this paper
  27. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer · Frank‐Jan H. Drost · 2019 · 656 citations · Cited by this paper
  28. Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making · Wassim M. Abida · 2017 · 544 citations · Cited by this paper
  29. Prevalence of incidental prostate cancer: A systematic review of autopsy studies · Katy Bell · 2015 · 453 citations · Cited by this paper
  30. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment · Scott Arthur Tomlins · 2015 · 403 citations · Cited by this paper
  31. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score · Leander Van Neste · 2016 · 380 citations · Cited by this paper
  32. The DNA methylation landscape of advanced prostate cancer · Shuang George Zhao · 2020 · 368 citations · Cited by this paper
  33. Epigenetic drivers of tumourigenesis and cancer metastasis · Aniruddha Chatterjee · 2017 · 346 citations · Cited by this paper
  34. Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy · Shuang George Zhao · 2017 · 324 citations · Cited by this paper
  35. Quantitation of GSTP1 Methylation in Non-neoplastic Prostatic Tissue and Organ-Confined Prostate Adenocarcinoma · Cármen Jerónimo · 2001 · 308 citations · Cited by this paper
  36. Prostate Cancer, Version 3.2024 · Edward Matthew Schaeffer · 2024 · 302 citations · Cited by this paper
  37. DNA Hypomethylation Arises Later in Prostate Cancer Progression than CpG Island Hypermethylation and Contributes to Metastatic Tumor Heterogeneity · Srinivasan Yegnasubramanian · 2008 · 297 citations · Cited by this paper
  38. The oncogene ERG: a key factor in prostate cancer · Patricia Adamo · 2015 · 291 citations · Cited by this paper
  39. Intratumor DNA Methylation Heterogeneity Reflects Clonal Evolution in Aggressive Prostate Cancer · David Brocks · 2014 · 273 citations · Cited by this paper

Source: OpenAlex (CC0)